- Home
- APLT vs ELTK Comparison
APLT vs ELTK Comparison
Compare APLT & ELTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- ELTK
- Stock Information
- Founded
- APLT 2016
- ELTK 1970
- Country
- APLT United States
- ELTK Israel
- Employees
- APLT N/A
- ELTK N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- ELTK Electrical Products
- Sector
- APLT Health Care
- ELTK Technology
- Exchange
- APLT Nasdaq
- ELTK Nasdaq
- Market Cap
- APLT 69.0M
- ELTK 67.9M
- IPO Year
- APLT 2019
- ELTK 1997
- Fundamental
- Price
- APLT $0.51
- ELTK $10.10
- Analyst Decision
- APLT Buy
- ELTK
- Analyst Count
- APLT 6
- ELTK 0
- Target Price
- APLT $6.10
- ELTK N/A
- AVG Volume (30 Days)
- APLT 893.4K
- ELTK 8.0K
- Earning Date
- APLT 08-13-2025
- ELTK 08-14-2025
- Dividend Yield
- APLT N/A
- ELTK 1.88%
- EPS Growth
- APLT N/A
- ELTK N/A
- EPS
- APLT N/A
- ELTK 0.45
- Revenue
- APLT $121,000.00
- ELTK $49,563,000.00
- Revenue This Year
- APLT $415.60
- ELTK $18.60
- Revenue Next Year
- APLT $1,323.96
- ELTK $9.04
- P/E Ratio
- APLT N/A
- ELTK $22.38
- Revenue Growth
- APLT N/A
- ELTK 6.75
- 52 Week Low
- APLT $0.30
- ELTK $7.65
- 52 Week High
- APLT $10.62
- ELTK $12.19
- Technical
- Relative Strength Index (RSI)
- APLT 61.88
- ELTK 44.19
- Support Level
- APLT $0.47
- ELTK $9.75
- Resistance Level
- APLT $0.53
- ELTK $10.54
- Average True Range (ATR)
- APLT 0.03
- ELTK 0.27
- MACD
- APLT 0.00
- ELTK -0.02
- Stochastic Oscillator
- APLT 83.33
- ELTK 44.30
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.